Potential Benefits of Tryptophan Metabolism to the Efficacy of Tocilizumab in COVID-19
Tocilizumab has been proposed as a means of opposing hyperinflammatory responses in intensive care patients with COVID-19. Here, we briefly discuss the potentially multiple, synergistic mechanisms whereby tocilizumab might exert therapeutic activity, mostly focusing on the production of tryptophan-d...
Gorde:
Egile Nagusiak: | , |
---|---|
Formatua: | Liburua |
Argitaratua: |
Frontiers Media S.A.,
2020-06-01T00:00:00Z.
|
Gaiak: | |
Sarrera elektronikoa: | Connect to this object online. |
Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
Izan zaitez lehena ohar bat uzten!